Clinical Trial Update: Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study [Phase 1]

View source ↗

Summary

A Phase 1 multicenter trial evaluating remimazolam infusion in patients undergoing kidney transplantation. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Transplantation

Drugs mentioned

• Remimazolam (remimazolam)

Snippet

Sponsor: Qianfoshan Hospital | Conditions: Chronic Kidney Diseases, Renal Transplantation | Phase 1 | Status: RECRUITING